Colette Cywes-Bentley, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acetylglucosamine | 12 | 2024 | 189 | 2.150 |
Why?
|
| Antibodies, Bacterial | 16 | 2023 | 1464 | 1.620 |
Why?
|
| Actinomycetales Infections | 6 | 2021 | 30 | 1.520 |
Why?
|
| Bacterial Vaccines | 6 | 2024 | 399 | 1.080 |
Why?
|
| Rhodococcus equi | 6 | 2021 | 16 | 1.070 |
Why?
|
| Horse Diseases | 6 | 2021 | 55 | 0.820 |
Why?
|
| Staphylococcus aureus | 9 | 2024 | 1450 | 0.700 |
Why?
|
| Polysaccharides, Bacterial | 8 | 2019 | 577 | 0.600 |
Why?
|
| Bacterial Capsules | 7 | 2015 | 241 | 0.550 |
Why?
|
| Streptococcus pyogenes | 6 | 2003 | 292 | 0.470 |
Why?
|
| Antigens, Bacterial | 2 | 2018 | 1140 | 0.440 |
Why?
|
| Horses | 8 | 2021 | 296 | 0.440 |
Why?
|
| Immunization, Passive | 3 | 2021 | 617 | 0.410 |
Why?
|
| Streptococcal Infections | 6 | 2020 | 617 | 0.350 |
Why?
|
| Pneumonia, Bacterial | 3 | 2021 | 316 | 0.340 |
Why?
|
| Mycoses | 1 | 2013 | 386 | 0.340 |
Why?
|
| Bacterial Infections | 2 | 2018 | 1390 | 0.320 |
Why?
|
| Bacterial Adhesion | 4 | 2007 | 304 | 0.310 |
Why?
|
| Staphylococcal Infections | 6 | 2024 | 1401 | 0.270 |
Why?
|
| Hyaluronic Acid | 4 | 2006 | 484 | 0.270 |
Why?
|
| beta-Glucans | 3 | 2018 | 123 | 0.260 |
Why?
|
| Opsonin Proteins | 5 | 2019 | 144 | 0.230 |
Why?
|
| Streptococcus equi | 2 | 2020 | 9 | 0.230 |
Why?
|
| Bacterial Proteins | 8 | 2021 | 3836 | 0.230 |
Why?
|
| Malaria | 1 | 2013 | 1225 | 0.220 |
Why?
|
| Animals, Newborn | 5 | 2021 | 2665 | 0.210 |
Why?
|
| Complement C1 | 2 | 2019 | 31 | 0.210 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2024 | 239 | 0.190 |
Why?
|
| Immunoglobulin G | 3 | 2019 | 4537 | 0.180 |
Why?
|
| Meningitis, Bacterial | 1 | 2023 | 222 | 0.180 |
Why?
|
| Virulence Factors | 3 | 2019 | 511 | 0.180 |
Why?
|
| Coagulase | 2 | 2012 | 53 | 0.180 |
Why?
|
| Bacteria | 3 | 2023 | 2190 | 0.170 |
Why?
|
| Gonorrhea | 1 | 2024 | 346 | 0.170 |
Why?
|
| Escherichia coli | 4 | 2023 | 4201 | 0.160 |
Why?
|
| Biofilms | 4 | 2018 | 625 | 0.160 |
Why?
|
| Neutrophil Activation | 1 | 2019 | 180 | 0.160 |
Why?
|
| Pharynx | 2 | 2001 | 432 | 0.160 |
Why?
|
| Immunization | 3 | 2020 | 1218 | 0.160 |
Why?
|
| Intestines | 2 | 2019 | 1908 | 0.150 |
Why?
|
| Phagocytosis | 4 | 2019 | 1525 | 0.150 |
Why?
|
| Vaccination | 3 | 2021 | 3369 | 0.150 |
Why?
|
| Vaccines, Conjugate | 3 | 2018 | 328 | 0.150 |
Why?
|
| Transport Vesicles | 1 | 2018 | 81 | 0.150 |
Why?
|
| Enterococcus faecalis | 1 | 2019 | 245 | 0.140 |
Why?
|
| Fungal Vaccines | 1 | 2016 | 7 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 3 | 2019 | 9187 | 0.130 |
Why?
|
| Animals | 30 | 2024 | 168079 | 0.130 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2015 | 39 | 0.120 |
Why?
|
| Malaria Vaccines | 1 | 2016 | 163 | 0.120 |
Why?
|
| Keratinocytes | 5 | 2003 | 790 | 0.120 |
Why?
|
| Enterobacteriaceae | 1 | 2016 | 161 | 0.120 |
Why?
|
| Escherichia coli Vaccines | 1 | 2014 | 10 | 0.120 |
Why?
|
| Shiga Toxin | 1 | 2014 | 36 | 0.110 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 1 | 2014 | 26 | 0.110 |
Why?
|
| Eye Infections | 1 | 2014 | 62 | 0.110 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2016 | 187 | 0.110 |
Why?
|
| beta-Lactamases | 1 | 2016 | 304 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2018 | 1607 | 0.110 |
Why?
|
| Mice | 20 | 2024 | 81326 | 0.110 |
Why?
|
| Galactans | 1 | 2012 | 31 | 0.100 |
Why?
|
| Yersinia pestis | 1 | 2012 | 33 | 0.100 |
Why?
|
| Gram-Positive Bacteria | 1 | 2013 | 176 | 0.100 |
Why?
|
| Plasmodium berghei | 1 | 2013 | 159 | 0.100 |
Why?
|
| Burkholderia cepacia complex | 1 | 2012 | 24 | 0.100 |
Why?
|
| Bacillus subtilis | 1 | 2015 | 351 | 0.100 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2012 | 1131 | 0.100 |
Why?
|
| Burkholderia Infections | 1 | 2012 | 41 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2013 | 271 | 0.090 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2015 | 585 | 0.090 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 18220 | 0.090 |
Why?
|
| Fungi | 1 | 2013 | 337 | 0.090 |
Why?
|
| Eye | 1 | 2014 | 713 | 0.090 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 518 | 0.090 |
Why?
|
| Pneumonia | 1 | 2021 | 2142 | 0.080 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 724 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 22127 | 0.080 |
Why?
|
| Microscopy, Confocal | 4 | 2012 | 1967 | 0.080 |
Why?
|
| Fibrinogen | 2 | 2012 | 888 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 3 | 2024 | 6199 | 0.070 |
Why?
|
| Rabbits | 3 | 2024 | 4750 | 0.070 |
Why?
|
| Graft vs Host Disease | 1 | 2019 | 3025 | 0.070 |
Why?
|
| Streptococcus | 1 | 2006 | 197 | 0.070 |
Why?
|
| Phospholipases A | 1 | 2006 | 204 | 0.060 |
Why?
|
| Streptolysins | 2 | 2003 | 57 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 1448 | 0.060 |
Why?
|
| Aminoquinolines | 1 | 2004 | 106 | 0.060 |
Why?
|
| Staphylococcal Vaccines | 1 | 2024 | 30 | 0.060 |
Why?
|
| Bacteriophages | 1 | 2006 | 378 | 0.050 |
Why?
|
| Protein Binding | 2 | 2013 | 9297 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2004 | 4340 | 0.050 |
Why?
|
| Neutrophils | 4 | 2019 | 3763 | 0.050 |
Why?
|
| Genome, Bacterial | 2 | 2019 | 785 | 0.050 |
Why?
|
| NAD+ Nucleosidase | 1 | 2002 | 43 | 0.050 |
Why?
|
| Streptococcus agalactiae | 1 | 2003 | 337 | 0.050 |
Why?
|
| Urethra | 1 | 2024 | 405 | 0.050 |
Why?
|
| Intercellular Junctions | 1 | 2001 | 195 | 0.050 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2001 | 79 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2001 | 213 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2001 | 242 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2003 | 737 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2013 | 10088 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2015 | 6567 | 0.040 |
Why?
|
| Interleukins | 2 | 2015 | 782 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2004 | 877 | 0.040 |
Why?
|
| Virulence | 2 | 2019 | 1296 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2020 | 555 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2001 | 23416 | 0.040 |
Why?
|
| Imidazoles | 1 | 2004 | 1172 | 0.040 |
Why?
|
| Monocytes | 2 | 2004 | 2570 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 2018 | 206 | 0.040 |
Why?
|
| Abdominal Abscess | 1 | 1999 | 153 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2004 | 1348 | 0.040 |
Why?
|
| Epitopes | 1 | 2024 | 2504 | 0.040 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 696 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2006 | 1530 | 0.040 |
Why?
|
| Immune Sera | 2 | 2012 | 605 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 2199 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2001 | 1169 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2007 | 2477 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2018 | 5406 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2002 | 923 | 0.030 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 342 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2018 | 445 | 0.030 |
Why?
|
| Female | 14 | 2024 | 392544 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2004 | 3661 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2015 | 101 | 0.030 |
Why?
|
| Plasma | 1 | 2019 | 586 | 0.030 |
Why?
|
| Mutation | 3 | 2019 | 30002 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2004 | 2307 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 2012 | 1059 | 0.030 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1998 | 403 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 2802 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2015 | 363 | 0.030 |
Why?
|
| Peptides | 1 | 2006 | 4353 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2006 | 18926 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2015 | 136 | 0.030 |
Why?
|
| Humans | 20 | 2024 | 761208 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2004 | 8300 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2015 | 556 | 0.030 |
Why?
|
| Antitoxins | 1 | 2014 | 77 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2014 | 150 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3696 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 1978 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2012 | 5871 | 0.030 |
Why?
|
| Siphonaptera | 1 | 2012 | 6 | 0.030 |
Why?
|
| Immobilized Proteins | 1 | 2012 | 24 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 39957 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2014 | 236 | 0.030 |
Why?
|
| Immunotherapy | 2 | 2023 | 4642 | 0.030 |
Why?
|
| Congo Red | 1 | 2012 | 48 | 0.030 |
Why?
|
| Goats | 1 | 2012 | 165 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 1999 | 1891 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 2426 | 0.030 |
Why?
|
| Blood Bactericidal Activity | 1 | 2012 | 124 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2012 | 641 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2015 | 1162 | 0.020 |
Why?
|
| Color | 1 | 2012 | 297 | 0.020 |
Why?
|
| Phagocytes | 1 | 2012 | 294 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2014 | 1128 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3634 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 894 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2012 | 515 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2018 | 3933 | 0.020 |
Why?
|
| Male | 9 | 2021 | 360693 | 0.020 |
Why?
|
| Swine | 1 | 2019 | 5909 | 0.020 |
Why?
|
| Sepsis | 2 | 2003 | 2585 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2015 | 1058 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2012 | 1351 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2016 | 1048 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 983 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3778 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2014 | 913 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2016 | 1050 | 0.020 |
Why?
|
| Phylogeny | 1 | 2015 | 2809 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 7407 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 9520 | 0.020 |
Why?
|
| Skin | 1 | 2001 | 4473 | 0.020 |
Why?
|
| Phospholipases A2 | 1 | 2006 | 197 | 0.020 |
Why?
|
| Cornea | 1 | 2014 | 1327 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 1882 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2006 | 328 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4372 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 198 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 2328 | 0.020 |
Why?
|
| Temperature | 1 | 2012 | 2219 | 0.020 |
Why?
|
| Bacteremia | 1 | 2012 | 978 | 0.020 |
Why?
|
| Membrane Fusion | 1 | 2006 | 265 | 0.020 |
Why?
|
| Interferon Inducers | 1 | 2004 | 25 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1998 | 4935 | 0.010 |
Why?
|
| Ligands | 2 | 2004 | 3264 | 0.010 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 1935 | 0.010 |
Why?
|
| Integrin alphaXbeta2 | 1 | 2003 | 29 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4739 | 0.010 |
Why?
|
| Complement Factor B | 1 | 2003 | 57 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 1 | 2003 | 286 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 2001 | 2635 | 0.010 |
Why?
|
| Serum | 1 | 2003 | 208 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18384 | 0.010 |
Why?
|
| Complement C3 | 1 | 2003 | 434 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 680 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 575 | 0.010 |
Why?
|
| Genotype | 1 | 2015 | 12985 | 0.010 |
Why?
|
| Soft Tissue Infections | 1 | 2003 | 168 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2001 | 453 | 0.010 |
Why?
|
| Hemolysis | 1 | 2003 | 415 | 0.010 |
Why?
|
| Operon | 1 | 2001 | 372 | 0.010 |
Why?
|
| Peritoneum | 1 | 2001 | 225 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2006 | 1936 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 8003 | 0.010 |
Why?
|
| Papio | 1 | 2001 | 669 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1240 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 413 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 834 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 1009 | 0.010 |
Why?
|
| Adhesins, Bacterial | 1 | 1998 | 118 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1518 | 0.010 |
Why?
|
| Solubility | 1 | 1999 | 1085 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 2261 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 1999 | 823 | 0.010 |
Why?
|
| Lung | 1 | 2015 | 9979 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4167 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 2062 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1999 | 1848 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2003 | 2658 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13402 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10756 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 6312 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 17598 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 2814 | 0.010 |
Why?
|
| Child | 1 | 2001 | 80152 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3726 | 0.010 |
Why?
|
| Survival Rate | 1 | 2006 | 12728 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2004 | 3044 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 5778 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 5773 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 5748 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 6504 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 6067 | 0.000 |
Why?
|
| Base Sequence | 1 | 1998 | 12404 | 0.000 |
Why?
|
| Apoptosis | 1 | 2002 | 9477 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1999 | 12747 | 0.000 |
Why?
|
| Cytokines | 1 | 1999 | 7386 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2004 | 26199 | 0.000 |
Why?
|
| Rats | 1 | 1999 | 23704 | 0.000 |
Why?
|
| Adult | 2 | 2004 | 221119 | 0.000 |
Why?
|